Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESH AL 2020 | Advances in the field of HSCT

Sergio Giralt • 7 Jul 2020
ESH AL 2020
General Leukemia Anti-thymocyte globulin

The success of hematopoietic stem cell transplantation (HSCT) has resulted from continuous advances in the field. Sergio Giralt, MD, Memorial Sloan-Kettering Cancer Center, New York, NY, discusses the progress in the field since the first HSCT was performed fifty years ago. Dr Giralt reveals that many challenges remain, particularly in minimizing disease relapse and toxicities. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Sergio Giralt

0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:12
An update in cellular therapies: gene editing for SCD and immunotherapies for MM
Sergio Giralt • 8 Dec 2023
0:59
The role of radioimmunoconjugates in AML treatment: insights from the SIERRA trial
Sergio Giralt • 8 Dec 2023

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
1:40
The role of CPX-351 in the AML treatment landscape & insights into the AMLSG 30-18 trial
Felicitas Thol • 19 Apr 2024
The content of VJHemOnc is intended for healthcare professionals